compound 3 [PMID: 21650226]   Click here for help

GtoPdb Ligand ID: 8745

Compound class: Synthetic organic
Comment: Compound 3 is reported as a thiazolidinedione analogue inhibitor of 15-hydroxyprostaglandin dehydrogenase (HPGD) [2]. This compound is also example 11 in patent US8637558 B2, which describes its use for the prevention or treatment of cardiovascular disease, gastrointestinal disease, renal disease and other conditions by increasing prostaglandin levels via inhibition of HPGD-induced prostaglandin metabolism [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 80.7
Molecular weight 365.09
XLogP 5.23
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1NC(=O)C(=Cc2ccc(c(c2)Cl)OCCC2CCCCC2)S1
Isomeric SMILES O=C1NC(=O)/C(=C/c2ccc(c(c2)Cl)OCCC2CCCCC2)/S1
InChI InChI=1S/C18H20ClNO3S/c19-14-10-13(11-16-17(21)20-18(22)24-16)6-7-15(14)23-9-8-12-4-2-1-3-5-12/h6-7,10-12H,1-5,8-9H2,(H,20,21,22)/b16-11-
InChI Key DBBGLVJTGXKCHY-WJDWOHSUSA-N
References
1. Cho H, Wu Y, Choi C-H. (2014)
Thiazolidinedione derivative and use thereof.
Patent number: US8637558 B2. Assignee: Industry-Academic Cooperation Foundation, Chosun University. Priority date: 30/12/2008. Publication date: 28/01/2014.
2. Wu Y, Karna S, Choi CH, Tong M, Tai HH, Na DH, Jang CH, Cho H. (2011)
Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.
J Med Chem, 54 (14): 5260-4. [PMID:21650226]